Clinical Study on the Treatment of Refractory Rheumatoid Arthritis With UTAA91 Injection

NCT06982547 · clinicaltrials.gov ↗
EARLY_PHASE1
Phase
NOT_YET_RECRUITING
Status
24
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

PersonGen BioTherapeutics (Suzhou) Co., Ltd.